{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T02:39:17Z","timestamp":1794191957809,"version":"4.8.0"},"reference-count":120,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"The Royal Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018641","name":"Dairy Research Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018641","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R007446\/1"],"award-info":[{"award-number":["MR\/R007446\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer's Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Neurosciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.tins.2025.10.006","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T21:38:37Z","timestamp":1762465117000},"page":"952-963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rethinking neurodegeneration through a co-proteinopathy lens"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5486-278X","authenticated-orcid":false,"given":"Yu P.","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Kedia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tins.2025.10.006_bb0005","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","article-title":"Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease","volume":"13","author":"Emin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"\u03b1-Synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.10.006_bb0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.neurol.2016.05.002","article-title":"Neurodegeneration in tauopathies and synucleinopathies","volume":"172","author":"Foguem","year":"2016","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.tins.2025.10.006_bb0020","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/nm1113","article-title":"Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs","volume":"10","author":"Forman","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2025.10.006_bb0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12964-024-01791-8","article-title":"Misfolding and aggregation in neurodegenerative diseases: protein quality control machinery as potential therapeutic clearance pathways","volume":"22","author":"Kosz\u0142a","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.tins.2025.10.006_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcab147","article-title":"Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer\u2019s disease","volume":"3","author":"Sideris","year":"2021","journal-title":"Brain Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0035","doi-asserted-by":"crossref","DOI":"10.1111\/ene.16206","article-title":"Misfolded alpha-synuclein in amyotrophic lateral sclerosis: implications for diagnosis and treatment","volume":"31","author":"Smith","year":"2024","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40035-024-00407-y","article-title":"Overlaps and divergences between tauopathies and synucleinopathies: a duet of neurodegeneration","volume":"13","author":"Li","year":"2024","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.tins.2025.10.006_bb0045","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11064-025-04399-7","article-title":"Unravelling the proteinopathic engagement of \u03b1-synuclein, tau, and amyloid beta in Parkinson\u2019s disease: mitochondrial collapse as a pivotal driver of neurodegeneration","volume":"50","author":"Sahoo","year":"2025","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.tins.2025.10.006_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-\u03b2 attenuates Alzheimer-disease-like pathology in the PDAPP mouse","volume":"400","author":"Schenk","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.10.006_bb0055","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1016\/j.cell.2024.08.024","article-title":"Co-opting templated aggregation to degrade pathogenic tau assemblies and improve motor function","volume":"187","author":"Miller","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.10.006_bb0060","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13024-024-00730-y","article-title":"Single-domain antibody-based protein degrader for synucleinopathies","volume":"19","author":"Jiang","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.tins.2025.10.006_bb0065","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","article-title":"Second-generation anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: current landscape and future perspectives","volume":"14","author":"Kim","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.tins.2025.10.006_bb0070","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.tins.2025.10.006_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tins.2025.10.006_bb0080","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson\u2019s disease","volume":"30","author":"Pagano","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2025.10.006_bb0085","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/brain\/awae327","article-title":"Default mode network tau predicts future clinical decline in atypical early Alzheimer\u2019s disease","volume":"148","author":"Katsumi","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.tins.2025.10.006_bb0090","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40035-025-00479-4","article-title":"Dual modulation of amyloid beta and tau aggregation and dissociation in Alzheimer\u2019s disease: a comprehensive review of the characteristics and therapeutic strategies","volume":"14","author":"Nam","year":"2025","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.tins.2025.10.006_bb0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jalz.2016.07.005","article-title":"The DIAN-TU Next Generation Alzheimer\u2019s prevention trial: adaptive design and disease progression model","volume":"13","author":"Bateman","year":"2017","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.10.006_bb0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41541-024-00942-9","article-title":"A multi-targeting immunotherapy ameliorates multiple facets of Alzheimer\u2019s disease in 3xTg mice","volume":"9","author":"Feng","year":"2024","journal-title":"NPJ Vacc."},{"key":"10.1016\/j.tins.2025.10.006_bb0105","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1093\/jnen\/nlae093","article-title":"AMPA receptors in Alzheimer disease: pathological changes and potential therapeutic targets","volume":"83","author":"Ning","year":"2024","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/bs.apcsb.2024.09.009","article-title":"Nuclear podosomes regulates cellular migration in Tau and Alzheimer\u2019s disease","volume":"143","author":"Qureshi","year":"2025","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.tins.2025.10.006_bb0115","series-title":"Tau Biology","first-page":"81","article-title":"Tau and axonal transport misregulation in tauopathies","author":"Combs","year":"2019"},{"key":"10.1016\/j.tins.2025.10.006_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2024.168615","article-title":"Interplay of proteostasis capacity and protein aggregation: implications for cellular function and disease","volume":"436","author":"Hipp","year":"2024","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.tins.2025.10.006_bb0125","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1189809","article-title":"Concomitant protein pathogenesis in Parkinson\u2019s disease and perspective mechanisms","volume":"15","author":"Han","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2025.10.006_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-030-40204-4_4","article-title":"Challenging proteostasis: role of the chaperone network to control aggregation-prone proteins in human disease","volume":"1243","author":"Sinnige","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.tins.2025.10.006_bb0135","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nature10317","article-title":"Molecular chaperones in protein folding and proteostasis","volume":"475","author":"Hartl","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.10.006_bb0140","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.1007\/s12035-023-03801-1","article-title":"Clusterin is a potential therapeutic target in Alzheimer\u2019s disease","volume":"61","author":"Palihati","year":"2024","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tins.2025.10.006_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/nep3.68","article-title":"Decoding the role of large heat shock proteins in the progression of neuroinflammation-mediated neurodegenerative disorders","volume":"3","author":"Saxena","year":"2025","journal-title":"Neuroprotection"},{"key":"10.1016\/j.tins.2025.10.006_bb0150","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1038\/s41467-024-53547-0","article-title":"ASC specks as a single-molecule fluid biomarker of inflammation in neurodegenerative diseases","volume":"15","author":"Lobanova","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0155","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.bbadis.2010.07.014","article-title":"New insights into the role of mitochondrial dysfunction and protein aggregation in Parkinson\u2019s disease","volume":"1802","author":"Xie","year":"2010","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Basis Dis."},{"key":"10.1016\/j.tins.2025.10.006_bb0160","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1096\/fj.201601184","article-title":"Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain","volume":"31","author":"Currais","year":"2016","journal-title":"FASEB J."},{"key":"10.1016\/j.tins.2025.10.006_bb0165","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1750-3639.2009.00326.x","article-title":"Protein targets of oxidative damage in human neurodegenerative diseases with abnormal protein aggregates","volume":"20","author":"Mart\u00ednez","year":"2010","journal-title":"Brain Pathol."},{"key":"10.1016\/j.tins.2025.10.006_bb0170","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1038\/s41467-022-32350-9","article-title":"Molecular mechanism for the synchronized electrostatic coacervation and co-aggregation of alpha-synuclein and tau","volume":"13","author":"Gracia","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0175","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1074\/jbc.RA119.012284","article-title":"Structural basis of the interplay between \u03b1-synuclein and Tau in regulating pathological amyloid aggregation","volume":"295","author":"Lu","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.10.006_bb0180","doi-asserted-by":"crossref","first-page":"18276","DOI":"10.1021\/jacs.3c03212","article-title":"\u03b1-Synuclein aggregation is triggered by oligomeric amyloid-\u03b2 42 via heterogeneous primary nucleation","volume":"145","author":"Vadukul","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tins.2025.10.006_bb0185","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-chembioeng-060816-101404","article-title":"Driving forces for nonnative protein aggregation and approaches to predict aggregation-prone regions","volume":"8","author":"Meric","year":"2017","journal-title":"Annu. Rev. Chem. Biomol. Eng."},{"key":"10.1016\/j.tins.2025.10.006_bb0190","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.abb.2007.08.033","article-title":"A polymer physics perspective on driving forces and mechanisms for protein aggregation","volume":"469","author":"Pappu","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tins.2025.10.006_bb0195","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1002\/jps.22705","article-title":"Aggregation in protein-based biotherapeutics: computational studies and tools to identify aggregation-prone regions","volume":"100","author":"Agrawal","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tins.2025.10.006_bb0200","doi-asserted-by":"crossref","first-page":"6614","DOI":"10.1021\/jp911706q","article-title":"Prediction of aggregation prone regions of therapeutic proteins","volume":"114","author":"Chennamsetty","year":"2010","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.tins.2025.10.006_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2020.106507","article-title":"Biophysical processes underlying cross-seeding in amyloid aggregation and implications in amyloid pathology","volume":"269","author":"Ivanova","year":"2021","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.tins.2025.10.006_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2025.1570553","article-title":"\u03b1-Synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies","volume":"19","author":"Padilla-God\u00ednez","year":"2025","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.tins.2025.10.006_bb0215","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41467-022-28955-9","article-title":"Mapping the sequence specificity of heterotypic amyloid interactions enables the identification of aggregation modifiers","volume":"13","author":"Louros","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0220","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/brain\/awad289","article-title":"Cross-seeding by prion protein inactivates TDP-43","volume":"147","author":"Polido","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.tins.2025.10.006_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.151053","article-title":"Liquid-liquid phase separation of tau and \u03b1-synuclein: a new pathway of overlapping neuropathologies","volume":"741","author":"Rodr\u00edguez","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2023.140950","article-title":"Heterotypic liquid-liquid phase separation of tau and \u03b1-synuclein: implications for overlapping neuropathologies","volume":"1871","author":"Foressi","year":"2023","journal-title":"Biochim. Biophys. Acta (BBA) Proteins Proteom."},{"key":"10.1016\/j.tins.2025.10.006_bb0235","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/pro.4025","article-title":"Interplay between tau and \u03b1-synuclein liquid\u2013liquid phase separation","volume":"30","author":"Siegert","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.tins.2025.10.006_bb0240","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.bbrc.2021.03.091","article-title":"Tau induces formation of \u03b1-synuclein filaments with distinct molecular conformations","volume":"554","author":"Hojjatian","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0245","article-title":"Heterotypic seeding generates mixed amyloid polymorphs","volume":"4","author":"Banerjee","year":"2024","journal-title":"Small Sci."},{"key":"10.1016\/j.tins.2025.10.006_bb0250","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1021\/acs.biochem.9b00215","article-title":"Tau interacts with the C-terminal region of \u03b1-synuclein, promoting formation of toxic aggregates with distinct molecular conformations","volume":"58","author":"Dasari","year":"2019","journal-title":"Biochemistry"},{"key":"10.1016\/j.tins.2025.10.006_bb0255","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neuroscience.2024.04.002","article-title":"The co-oligomers of A\u03b242 and human islet amyloid polypeptide exacerbate neurotoxicity and Alzheimer-like pathology at cellular level","volume":"547","author":"Deng","year":"2024","journal-title":"Neuroscience"},{"key":"10.1016\/j.tins.2025.10.006_bb0260","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1742-4658.2005.04571.x","article-title":"Characterization of \u03b1-synuclein aggregation and synergistic toxicity with protein tau in yeast","volume":"272","author":"Zabrocki","year":"2005","journal-title":"FEBS J."},{"key":"10.1016\/j.tins.2025.10.006_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2021.166203","article-title":"Human amyloid beta and \u03b1-synuclein co-expression in neurons impair behavior and recapitulate features for Lewy body dementia in Caenorhabditis elegans","volume":"1867","author":"Huang","year":"2021","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.tins.2025.10.006_bb0270","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1016\/j.neuron.2024.08.003","article-title":"Gut-induced alpha-synuclein and Tau propagation initiate Parkinson\u2019s and Alzheimer\u2019s disease co-pathology and behavior impairments","volume":"112","author":"Xiang","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.tins.2025.10.006_bb0275","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/jnnp.52.6.701","article-title":"A pathological study of the association between Lewy body disease and Alzheimer\u2019s disease","volume":"52","author":"Gibb","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.tins.2025.10.006_bb0280","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jnen\/64.2.156","article-title":"Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: evidence from the Baltimore Longitudinal Study of Aging (BLSA)","volume":"64","author":"Mikolaenko","year":"2005","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0285","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.biopsych.2014.12.019","article-title":"Pathological interface between oligomeric alpha-synuclein and Tau in synucleinopathies","volume":"78","author":"Sengupta","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.tins.2025.10.006_bb0290","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnen\/62.4.389","article-title":"Colocalization of Tau and alpha-synuclein epitopes in Lewy bodies","volume":"62","author":"Ishizawa","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0295","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000354670","article-title":"The significance of \u03b1-synuclein, amyloid-\u03b2 and Tau pathologies in Parkinson\u2019s disease progression and related dementia","volume":"13","author":"Compta","year":"2014","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.tins.2025.10.006_bb0300","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0006-8993(99)01848-X","article-title":"Cellular co-localization of phosphorylated tau- and NACP\/\u03b1-synuclein-epitopes in Lewy bodies in sporadic Parkinson\u2019s disease and in dementia with Lewy bodies","volume":"843","author":"Arima","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.tins.2025.10.006_bb0305","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1093\/jnen\/nlw070","article-title":"Distribution and load of amyloid-\u03b2 pathology in Parkinson disease and dementia with Lewy bodies","volume":"75","author":"Hepp","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0310","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/NEN.0b013e31817713b5","article-title":"Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies","volume":"67","author":"Uryu","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0315","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ana.21154","article-title":"TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer\u2019s disease","volume":"61","author":"Amador-Ortiz","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0320","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.3233\/JAD-180169","article-title":"TDP-43 and Alzheimer\u2019s disease pathologic subtype in non-amnestic Alzheimer\u2019s disease dementia","volume":"64","author":"Sahoo","year":"2018","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.tins.2025.10.006_bb0325","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae442","article-title":"Amygdala-predominant \u03b1-synuclein pathology is associated with exacerbated hippocampal neuron loss in Alzheimer\u2019s disease","volume":"6","author":"Gawor","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0330","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1093\/brain\/awae372","article-title":"Patterns of tau, amyloid and synuclein pathology in ageing, Alzheimer\u2019s disease and synucleinopathies","volume":"148","author":"Colloby","year":"2025","journal-title":"Brain"},{"key":"10.1016\/j.tins.2025.10.006_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq5923","article-title":"Proteomics of brain, CSF, and plasma identifies molecular signatures for distinguishing sporadic and genetic Alzheimer\u2019s disease","volume":"15","author":"Sung","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tins.2025.10.006_bb0340","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s12035-024-04422-y","article-title":"Brain proteome profiling reveals common and divergent signatures in Parkinson\u2019s disease, multiple system atrophy, and progressive supranuclear palsy","volume":"62","author":"Dick","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.tins.2025.10.006_bb0345","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/brain\/awad388","article-title":"Nigrostriatal tau pathology in parkinsonism and Parkinson\u2019s disease","volume":"147","author":"Chu","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.tins.2025.10.006_bb0350","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/s41467-022-30461-x","article-title":"Hyperphosphorylated tau self-assembles into amorphous aggregates eliciting TLR4-dependent responses","volume":"13","author":"Meng","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0355","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/alz.13711","article-title":"Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates","volume":"20","author":"Islam","year":"2024","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.10.006_bb0360","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ab.2018.09.011","article-title":"Detection of amyloid \u03b2 oligomers toward early diagnosis of Alzheimer\u2019s disease","volume":"566","author":"Hwang","year":"2019","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.tins.2025.10.006_bb0365","doi-asserted-by":"crossref","first-page":"15254","DOI":"10.1021\/acs.analchem.3c02515","article-title":"Imaging protein aggregates in Parkinson\u2019s disease serum using aptamer-assisted single-molecule pull-down","volume":"95","author":"Zhang","year":"2023","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tins.2025.10.006_bb0370","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/brain\/awab306","article-title":"Imaging protein aggregates in the serum and cerebrospinal fluid in Parkinson\u2019s disease","volume":"145","author":"Lobanova","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.tins.2025.10.006_bb0375","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae178","article-title":"Single molecule characterisation of salivary protein aggregates from Parkinson\u2019s disease patients \u2013 a pilot study","volume":"6","author":"Furlepa","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105947","article-title":"Oligomeric \u03b1-synuclein and tau aggregates in NDEVs differentiate Parkinson\u2019s disease from atypical parkinsonisms","volume":"176","author":"Meloni","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.tins.2025.10.006_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104682","article-title":"Rapid, scalable assay of amylin-\u03b2 amyloid co-aggregation in brain tissue and blood","volume":"299","author":"Kotiya","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tins.2025.10.006_bb0390","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/jps.24157","article-title":"Transmission electron microscopy as an orthogonal method to characterize protein aggregates","volume":"104","author":"Sung","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tins.2025.10.006_bb0395","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.abb.2019.02.001","article-title":"Atomic force microscopy for single molecule characterisation of protein aggregation","volume":"664","author":"Ruggeri","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.tins.2025.10.006_bb0400","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/j.cell.2024.02.033","article-title":"Unraveling cellular complexity with transient adapters in highly multiplexed super-resolution imaging","volume":"187","author":"Schueder","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.tins.2025.10.006_bb0405","doi-asserted-by":"crossref","first-page":"7238","DOI":"10.1038\/s41467-023-42834-x","article-title":"NULISA: a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing","volume":"14","author":"Feng","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0410","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1038\/s41591-025-03834-0","article-title":"The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging","volume":"31","author":"Imam","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.tins.2025.10.006_bb0415","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/s43587-025-00872-8","article-title":"Large-scale plasma proteomic profiling unveils diagnostic biomarkers and pathways for Alzheimer\u2019s disease","volume":"5","author":"Heo","year":"2025","journal-title":"Nat. Aging"},{"key":"10.1016\/j.tins.2025.10.006_bb0420","doi-asserted-by":"crossref","DOI":"10.1002\/alz.075525","article-title":"Discovery and optimization of the first-in-class TDP-43 PET tracer","volume":"19","author":"Seredenina","year":"2023","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.10.006_bb0425","doi-asserted-by":"crossref","DOI":"10.1002\/alz.14628","article-title":"Parkinsonism in Alzheimer\u2019s disease without Lewy bodies in association with nigral neuron loss: a data-driven clinicopathologic study","volume":"21","author":"Ono","year":"2025","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.10.006_bb0430","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1073\/pnas.1207586110","article-title":"HDAC6 mutations rescue human tau-induced microtubule defects in Drosophila","volume":"110","author":"Xiong","year":"2013","journal-title":"Proc. Natl Acad. Sci. U. S. A."},{"key":"10.1016\/j.tins.2025.10.006_bb0435","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"\u03b1-Synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"Kontopoulos","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tins.2025.10.006_bb0440","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1038\/s41598-020-62678-5","article-title":"Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity","volume":"10","author":"Francelle","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tins.2025.10.006_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1281338","article-title":"Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer\u2019s disease","volume":"15","author":"Barmaki","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.tins.2025.10.006_bb0450","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bbrc.2020.12.113","article-title":"Strain-specific clearance of seed-dependent tau aggregation by lithium-induced autophagy","volume":"543","author":"Uddin","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-\u03b2 levels in a mouse model of Alzheimer\u2019s disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tins.2025.10.006_bb0460","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-215339","article-title":"Novel amylin analogues reduce amyloid-\u03b2 cross-seeding aggregation and neurotoxicity","volume":"87","author":"Dharmaraj","year":"2022","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.tins.2025.10.006_bb0465","article-title":"The association of circulating amylin with \u03b2-amyloid in familial Alzheimer\u2019s disease","volume":"7","author":"Ly","year":"2021","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.tins.2025.10.006_bb0470","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23956","article-title":"Amylin deposition in the brain: a second amyloid in Alzheimer disease?","volume":"74","author":"Jackson","year":"2013","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0475","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/ana.25570","article-title":"Amylin as a potential link between type 2 diabetes and Alzheimer disease","volume":"86","author":"Martinez-Valbuena","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0480","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-180421","article-title":"Neuroprotective effects of the amylin analog, pramlintide, on Alzheimer\u2019s disease are associated with oxidative stress regulation mechanisms","volume":"69","author":"Patrick","year":"2019","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.tins.2025.10.006_bb0485","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijbiomac.2017.05.048","article-title":"Protein aggregation: from background to inhibition strategies","volume":"103","author":"Alam","year":"2017","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tins.2025.10.006_bb0490","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.bbrc.2023.08.061","article-title":"Monovalent cations have different effects on the assembly kinetics and morphology of \u03b1-synuclein amyloid fibrils","volume":"679","author":"Havemeister","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0495","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1039\/C9RA09350H","article-title":"Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations","volume":"10","author":"Poulson","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.tins.2025.10.006_bb0500","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003537","article-title":"Cross-seeding of misfolded proteins: implications for etiology and pathogenesis of protein misfolding diseases","volume":"9","author":"Morales","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tins.2025.10.006_bb0505","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1093\/brain\/awac171","article-title":"Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson\u2019s disease","volume":"145","author":"Pan","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.tins.2025.10.006_bb0510","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.bbapap.2018.12.010","article-title":"Imaging individual protein aggregates to follow aggregation and determine the role of aggregates in neurodegenerative disease","volume":"1867","author":"De","year":"2019","journal-title":"Biochim. Biophys. Acta (BBA) Proteins Proteom."},{"key":"10.1016\/j.tins.2025.10.006_bb0515","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115155","article-title":"Albumin antagonizes Alzheimer\u2019s disease-related Tau pathology and enhances cognitive performance by inhibiting aberrant Tau aggregation","volume":"386","author":"Yang","year":"2025","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0520","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1021\/acs.jpcb.9b02381","article-title":"Dissecting the interactions between human serum albumin and \u03b1-synuclein: new insights on the factors influencing \u03b1-synuclein aggregation in biological fluids","volume":"123","author":"Bellomo","year":"2019","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.tins.2025.10.006_bb0525","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0458-20.2021","article-title":"Templated \u03b1-synuclein inclusion formation is independent of endogenous tau","volume":"8","author":"Stoyka","year":"2021","journal-title":"eNeuro"},{"key":"10.1016\/j.tins.2025.10.006_bb0530","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s40478-020-01079-1","article-title":"Clusterin ameliorates tau pathology in vivo by inhibiting fibril formation","volume":"8","author":"Wojtas","year":"2020","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0535","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1038\/s41467-021-25060-1","article-title":"The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model","volume":"12","author":"Yuste-Checa","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0540","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/mds.22971","article-title":"Incidental Lewy body disease: clinical comparison to a control cohort","volume":"25","author":"Adler","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.tins.2025.10.006_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40478-021-01233-3","article-title":"Predictors of cognitive impairment in primary age-related tauopathy: an autopsy study","volume":"9","author":"Iida","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.tins.2025.10.006_bb0550","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1093\/brain\/aww224","article-title":"TDP-43 stage, mixed pathologies, and clinical Alzheimer\u2019s-type dementia","volume":"139","author":"James","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.tins.2025.10.006_bb0555","doi-asserted-by":"crossref","first-page":"7281","DOI":"10.1523\/JNEUROSCI.0490-10.2010","article-title":"Synergistic interactions between A\u03b2, tau, and \u03b1-synuclein: acceleration of neuropathology and cognitive decline","volume":"30","author":"Clinton","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tins.2025.10.006_bb0560","first-page":"216","article-title":"Regional overlap of pathologies in Lewy body disorders","volume":"76","author":"Colom-Cadena","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tins.2025.10.006_bb0565","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00401-008-0439-2","article-title":"Enduring involvement of tau, \u03b2-amyloid, \u03b1-synuclein, ubiquitin and TDP-43 pathology in the amyotrophic lateral sclerosis\/parkinsonism\u2013dementia complex of Guam (ALS\/PDC)","volume":"116","author":"Miklossy","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tins.2025.10.006_bb0570","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1038\/s12276-020-00513-7","article-title":"The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies","volume":"52","author":"Jo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.tins.2025.10.006_bb0575","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3233\/JHD-140111","article-title":"The co-occurrence of Alzheimer\u2019s disease and Huntington\u2019s disease: a neuropathological study of 15 elderly Huntington\u2019s disease subjects","volume":"3","author":"Davis","year":"2014","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.tins.2025.10.006_bb0580","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1093\/brain\/aww021","article-title":"Is Huntington\u2019s disease a tauopathy?","volume":"139","author":"Gratuze","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.tins.2025.10.006_bb0585","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nature10324","article-title":"\u03b1-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation","volume":"477","author":"Bartels","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.tins.2025.10.006_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpc.2024.107202","article-title":"Amyloids, amorphous aggregates and assemblies of peptides \u2013 assessing aggregation","volume":"308","author":"Jukovi\u0107","year":"2024","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.tins.2025.10.006_bb0595","article-title":"Protein amyloid aggregate: structure and function","volume":"4","author":"Xu","year":"2023","journal-title":"Aggregate"},{"key":"10.1016\/j.tins.2025.10.006_bb0600","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1073\/pnas.0812227106","article-title":"Experimental characterization of disordered and ordered aggregates populated during the process of amyloid fibril formation","volume":"106","author":"Carulla","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Trends in Neurosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016622362500219X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016622362500219X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,21]],"date-time":"2025-12-21T07:52:50Z","timestamp":1766303570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016622362500219X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":120,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S016622362500219X"],"URL":"https:\/\/doi.org\/10.1016\/j.tins.2025.10.006","relation":{},"ISSN":["0166-2236"],"issn-type":[{"value":"0166-2236","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking neurodegeneration through a co-proteinopathy lens","name":"articletitle","label":"Article Title"},{"value":"Trends in Neurosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tins.2025.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}